Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2020 / Cilt: 30 - Sayı: 2

Azacytidine for Concurrent Acute Monocytic Leukemia and Multiple Myeloma in an Elderly Patient

Pages
110–112
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ATAS, U., TAZEGÜL, G., YÜCEL, O., ULAS, T., SALİM, O., ÜNDAR, L. (2020). Azacytidine for Concurrent Acute Monocytic Leukemia and Multiple Myeloma in an Elderly Patient. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 30 - Sayı: 2, 110–112. https://ajindex.com/articles/322741

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Oka S, Ono K, Nohgawa M. Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation. Ann Hematol 96: 1411-1413, 2017
  2. Murukutla S, Arora S, Bhatt VR, et al. Concurrent Acute Monoblastic Leukemia and Multiple Myeloma in a 66-Year-Old Chemotherapy-Naive Woman. World J Oncol 5: 68-71, 2014
  3. Lu-qun W, Hao L, Xiang-xin L, et al. A case of simultaneous occurrence of acute myeloid leukemia and multiple myeloma. BMC Cancer 15: 724, 2015
  4. Tian E, Tang H, Xu R, et al. Azacytidine induces necrosis of multiple myeloma cells through oxidative stress. Proteome Sci 11: 24, 2013.